🇺🇸 FDA
Patent

US 7592355

Quinolinone-carboxamide compounds as 5-HT, receptor agonists

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7592355 (Quinolinone-carboxamide compounds as 5-HT, receptor agonists) held by Theravance, Inc. expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/10, A61P1/14